| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 25/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
99% Pure Raw Powder Baricitinib CAS 1187594-09-7 Baricitinib for Anti-Rheumatic
| Product Name | Pharmaceutical Intermediate Baricitinib Raw Powder CAS 1187594-09-7 Baricitinib |
| CAS | 1187594-09-7 |
| Appearance | White powder |
| Molecular formula | C16H17N7O2S |
| Molecular Weight | 371.42 |
| Assay | 98% |
| Shelf Life | 24 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
|
What is Baricitinib ?
Baricitinib is an orally administered inhibitor of JAK kinases 1 and 2 and is commonly used in the treatment of moderate to severe active rheumatoid arthritis (RA) in adults. For patients with rheumatoid arthritis who have not previously used bio-DMARDS drugs, barikantinib can reduce the disease activity. |
Baricitinib (trade name Olumiant) is a drug for the treatment of rheumatoid arthritis (RA), being developed by Incyte
and Eli Lilly.It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2. The drug is approved in
Europe.
As of August 2016 31 clinical trials had been registered for baricitinib of which 24 had completed,and 4 of 6 phase 3
trials had completed.
){kind=link}